Tags

Type your tag names separated by a space and hit enter

Healing and prevention of relapse of reflux oesophagitis by cisapride.
Gut. 1991 Nov; 32(11):1280-5.Gut

Abstract

Altogether, 138 patients were included in a study aimed at evaluating the effect of cisapride on healing and relapse of oesophagitis shown endoscopically. In the first phase of the study cisapride was given in an open fashion at 10 mg four times a day for 8 to 16 weeks, and healing was obtained in 69% of patients. Healing occurred later in patients with grades II to IV oesophagitis. The total score for reflux symptoms decreased by 67%. Eighty of the healed patients were included in the second phase. They were randomly assigned to double blind treatment with either cisapride 10 mg (n = 37) or placebo (n = 43) twice a day. Control endoscopy was performed when symptoms recurred or at the end of the six month trial. The cumulative percentage of patients in remission was higher (p = 0.06, survival analysis) in the cisapride group than in the placebo group, the relapse rates being 20% and 39%. The duration of remission tended to be longer in patients with a lower initial degree of oesophagitis. Adverse effects were no more frequent with cisapride than with placebo. In conclusion, cisapride is efficacious in healing oesophagitis, and, unlike other gastrointestinal prokinetic drugs or low dose cimetidine (400-800 mg daily) or ranitidine (150 mg daily), it may prevent relapse of oesophagitis.

Authors+Show Affiliations

Institut Medico-Chirurgical, Tournai, Belgium.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

1752455

Citation

Toussaint, J, et al. "Healing and Prevention of Relapse of Reflux Oesophagitis By Cisapride." Gut, vol. 32, no. 11, 1991, pp. 1280-5.
Toussaint J, Gossuin A, Deruyttere M, et al. Healing and prevention of relapse of reflux oesophagitis by cisapride. Gut. 1991;32(11):1280-5.
Toussaint, J., Gossuin, A., Deruyttere, M., Hublé, F., & Devis, G. (1991). Healing and prevention of relapse of reflux oesophagitis by cisapride. Gut, 32(11), 1280-5.
Toussaint J, et al. Healing and Prevention of Relapse of Reflux Oesophagitis By Cisapride. Gut. 1991;32(11):1280-5. PubMed PMID: 1752455.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Healing and prevention of relapse of reflux oesophagitis by cisapride. AU - Toussaint,J, AU - Gossuin,A, AU - Deruyttere,M, AU - Hublé,F, AU - Devis,G, PY - 1991/11/1/pubmed PY - 1991/11/1/medline PY - 1991/11/1/entrez SP - 1280 EP - 5 JF - Gut JO - Gut VL - 32 IS - 11 N2 - Altogether, 138 patients were included in a study aimed at evaluating the effect of cisapride on healing and relapse of oesophagitis shown endoscopically. In the first phase of the study cisapride was given in an open fashion at 10 mg four times a day for 8 to 16 weeks, and healing was obtained in 69% of patients. Healing occurred later in patients with grades II to IV oesophagitis. The total score for reflux symptoms decreased by 67%. Eighty of the healed patients were included in the second phase. They were randomly assigned to double blind treatment with either cisapride 10 mg (n = 37) or placebo (n = 43) twice a day. Control endoscopy was performed when symptoms recurred or at the end of the six month trial. The cumulative percentage of patients in remission was higher (p = 0.06, survival analysis) in the cisapride group than in the placebo group, the relapse rates being 20% and 39%. The duration of remission tended to be longer in patients with a lower initial degree of oesophagitis. Adverse effects were no more frequent with cisapride than with placebo. In conclusion, cisapride is efficacious in healing oesophagitis, and, unlike other gastrointestinal prokinetic drugs or low dose cimetidine (400-800 mg daily) or ranitidine (150 mg daily), it may prevent relapse of oesophagitis. SN - 0017-5749 UR - https://www.unboundmedicine.com/medline/citation/1752455/Healing_and_prevention_of_relapse_of_reflux_oesophagitis_by_cisapride_ L2 - http://gut.bmj.com/cgi/pmidlookup?view=long&pmid=1752455 DB - PRIME DP - Unbound Medicine ER -